Guo Fang, Liu Juntian, Wang Chenjing, Liu Na, Lu Peipei
Department of Pharmacology, Xi'an Jiaotong University School of Medicine, People's Republic of China.
Biochem Biophys Res Commun. 2009 Dec 18;390(3):942-6. doi: 10.1016/j.bbrc.2009.10.082. Epub 2009 Oct 21.
Atherosclerosis is a chronic inflammatory disease in the vessel. As an inflammatory cytokine, C-reactive protein (CRP) participates in the pathogenesis of atherosclerosis through multiple bioactivities. It has been widely accepted that hyperfibrinogenemia is associated with the formation and progression of atherosclerosis. But, it is unknown whether fibrinogen exerts a pro-inflammatory effect on vascular smooth muscle cells (VSMCs). The purpose of the present study was to observe the effect of fibrinogen, fibrin, and fibrin degradation products (FDP) on CRP generation in VSMCs. CRP mRNA expression was identified with the reverse transcription polymerase chain reaction. CRP level in the supernatant of VSMCs was measured with the enzyme-linked immunosorbent assay. CRP expression in VSMCs was examined with the immunocytochemical method. The results showed that fibrinogen, fibrin, and FDP all induced CRP production in VSMCs both in mRNA level and in protein level in a time- and concentration-dependent manner. The potency is FDP>fibrin>fibrinogen, which seems to mean that their pro-inflammatory activity decreases with increase of molecular weight of these three proteins. The finding provides a new mechanism for atherogenic effect of fibrin(ogen) and FDP, and emphasizes the importance of therapy of hyperfibrinogenemia in atherosclerosis.
动脉粥样硬化是一种血管慢性炎症性疾病。作为一种炎症细胞因子,C反应蛋白(CRP)通过多种生物活性参与动脉粥样硬化的发病机制。高纤维蛋白原血症与动脉粥样硬化的形成和进展相关,这一点已被广泛接受。但是,纤维蛋白原是否对血管平滑肌细胞(VSMCs)发挥促炎作用尚不清楚。本研究的目的是观察纤维蛋白原、纤维蛋白和纤维蛋白降解产物(FDP)对VSMCs中CRP生成的影响。采用逆转录聚合酶链反应鉴定CRP mRNA表达。用酶联免疫吸附测定法检测VSMCs上清液中的CRP水平。用免疫细胞化学方法检测VSMCs中的CRP表达。结果表明,纤维蛋白原、纤维蛋白和FDP均能以时间和浓度依赖性方式在mRNA水平和蛋白水平诱导VSMCs产生CRP。其效力为FDP>纤维蛋白>纤维蛋白原,这似乎意味着这三种蛋白质的促炎活性随分子量增加而降低。该发现为纤维蛋白(原)和FDP的致动脉粥样硬化作用提供了一种新机制,并强调了治疗高纤维蛋白原血症在动脉粥样硬化中的重要性。